The Use of a Self-Occluding Topical Anasthetic in Daily Practice: A Non-Interventional Study.

CONCLUSION: Pliaglis was well-tolerated and provided adequate pain reduction prior to dermatological procedures. www.clinicaltrials.gov (NCT01800474). <p><em>J Drugs Dermatol. 2018;17(4):413-418.</em></p> <p>Partial study data have been presented at the Anti-Aging Medicine European Congress (AMEC), Paris; October, 24-25, 2014, and the European Academy of Dermatology and Venereology (EADV), Istanbul; October 2-6, 2013.</p>. PMID: 29601618 [PubMed - in process]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research